Peptinovo Biopharma Inc.

CIK 1868564 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Peptinovo Biopharma Inc..

Recent SEC filings

FiledFormAccession number
Sep 3, 2026C-TR0001868564-26-000008
Sep 2, 2026C-AR0001868564-26-000006
Aug 31, 2026C-U0001868564-26-000004
Aug 20, 2026C/A0001868564-26-000002
Oct 2, 2025C/A0001868564-25-000009
Sep 4, 2025C/A0001868564-25-000005
Mar 10, 2025C/A0001868564-25-000004
Mar 5, 2025C0001868564-25-000002
Dec 16, 2024D/A0001868564-24-000002
Sep 24, 2024D0001868564-24-000001
Jun 21, 2021D0001868564-21-000001